Literature DB >> 6602206

Stimulating effect of MDP and its adjuvant-active analogues on guinea pig fibroblasts for the production of thymocyte-activating factor.

H Iribe, T Koga, S Kotani, S Kusumoto, T Shiba.   

Abstract

Synthetic muramyl dipeptide (MDP) could stimulate skin fibroblasts of the guinea pig to produce thymocyte-activating factor, which augments the proliferative response of thymocytes to phytohemagglutinin (PHA). Adjuvant-active analogues of MDP also stimulated fibroblasts to produce the factor, whereas adjuvant-inactive analogues failed to do so. Thus a marked parallelism was found between adjuvant activity of these compounds and the stimulating effect on fibroblasts. Thymocyte-activating factor derived from MDP-stimulated fibroblasts was found in the fraction of mol wt 30,000-60,000 by gel filtration on a Sephacryl S-200 column. Furthermore, this factor did not exhibit T cell growth factor activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602206      PMCID: PMC2187029          DOI: 10.1084/jem.157.6.2190

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

Review 1.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

2.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

3.  Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor.

Authors:  J J Oppenheim; A Togawa; L Chedid; S Mizel
Journal:  Cell Immunol       Date:  1980-03-01       Impact factor: 4.868

4.  Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.

Authors:  H Iribe; T Koga; K Onoue; S Kotani; S Kusumoto; T Shiba
Journal:  Cell Immunol       Date:  1981-10       Impact factor: 4.868

5.  Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

Authors:  A Fontana; F Kristensen; R Dubs; D Gemsa; E Weber
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

6.  Production of T cell-activating monokine of guinea pig macrophages induced by MDP and partial characterization of the monokine.

Authors:  H Iribe; T Koga; K Onoue
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

7.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06

8.  Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.

Authors:  T A Luger; B M Stadler; B M Luger; B J Mathieson; M Mage; J A Schmidt; J J Oppenheim
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

9.  Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide.

Authors:  J P Tenu; E Lederer; J F Petit
Journal:  Eur J Immunol       Date:  1980-08       Impact factor: 5.532

10.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  11 in total

1.  Interleukin-1 mRNA-expressing macrophages in human chronically inflamed gingival tissues.

Authors:  Y Matsuki; T Yamamoto; K Hara
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 2.  Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.

Authors:  Mohammad Salem; Jakob Benedict Seidelin; Gerhard Rogler; Ole Haagen Nielsen
Journal:  Cell Mol Life Sci       Date:  2012-12-29       Impact factor: 9.261

3.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes.

Authors:  P C Lord; L M Wilmoth; S B Mizel; C E McCall
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides.

Authors:  H Takada; J Mihara; I Morisaki; S Hamada
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

5.  Spontaneous production of thymocyte-activating factor by human gingival fibroblasts and its autoregulatory effect on their proliferation.

Authors:  Y Ohmori; S Hanazawa; S Amano; T Miyoshi; K Hirose; S Kitano
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

6.  Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

Authors:  J Saklatvala; L M Pilsworth; S J Sarsfield; J Gavrilovic; J K Heath
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

7.  Production of a lymphocyte proliferation potentiating factor by purified polymorphonuclear leucocytes from mice and rabbits.

Authors:  F Goto; S Nakamura; K Goto; M Yoshinaga
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

8.  Differential responses of old human cartilage explants to synovial- and mononuclear-cell factors.

Authors:  O Huber-Bruning; B Wilbrink; J E Vernooij; J W Bijlsma; W den Otter; J Huber
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

9.  Studies of an interleukin 1 inhibitor: characterization and clinical significance.

Authors:  M A Berman; C I Sandborg; B S Calabia; B S Andrews; G J Friou
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  Synergism between muramyl dipeptide and lipopolysaccharide in the inhibition of glycosaminoglycan synthesis in cultured rat costal chondrocytes.

Authors:  T Ikebe; M Hirata; F Yanaga; T Koga
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.